Dolutegravir resistance in sub-Saharan Africa: should resource-limited settings be concerned for future treatment?
D Kamori, G Barabona - Frontiers in Virology, 2023 - frontiersin.org
In sub-Saharan Africa (SSA) the burden of non-nucleoside reverse transcriptase inhibitor
(NNRTI) HIV drug resistance (HIVDR) has been high over the years. Therefore, in 2018 the …
(NNRTI) HIV drug resistance (HIVDR) has been high over the years. Therefore, in 2018 the …
Comprehensive Analysis of HIV-1 Integrase Resistance-Related Mutations in African Countries
F Branda, M Giovanetti, L Sernicola, S Farcomeni… - Pathogens, 2024 - mdpi.com
The growing emergence of non-nucleoside reverse transcriptase inhibitor (NNRTI) HIV drug
resistance in sub-Saharan Africa (SSA) led to the World Health Organization (WHO) …
resistance in sub-Saharan Africa (SSA) led to the World Health Organization (WHO) …
Transmitted antiretroviral drug resistance to Integrase Strand Transfer Inhibitors class in São Paulo metropolitan area, Brazil
EM Matsuda, JH da Silva Santos… - AIDS Research and …, 2024 - liebertpub.com
A newer integrase strand transfer inhibitor (INSTI) cabotegravir was recently approved for
both therapy and prophylaxis and can play an essential role in the fight against AIDS. It …
both therapy and prophylaxis and can play an essential role in the fight against AIDS. It …